Loo, Y. S. (2023). Vitamin D3-associated lyotropic liquid crystalline nanoparticles for gemcitabine and thymoquinone delivery for treatment of luminal breast cancer with resistant characteristics.
Chicago Style (17th ed.) CitationLoo, Yan Shan. Vitamin D3-associated Lyotropic Liquid Crystalline Nanoparticles for Gemcitabine and Thymoquinone Delivery for Treatment of Luminal Breast Cancer with Resistant Characteristics. 2023.
MLA (9th ed.) CitationLoo, Yan Shan. Vitamin D3-associated Lyotropic Liquid Crystalline Nanoparticles for Gemcitabine and Thymoquinone Delivery for Treatment of Luminal Breast Cancer with Resistant Characteristics. 2023.
Warning: These citations may not always be 100% accurate.